Cargando…

Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy

BACKGROUND: In-depth phylogeographic analysis can reveal migration patterns relevant for public health planning. Here, as a model, we focused on the provenance, in the current Italian HCV subtype 1a epidemic, of the NS3 resistance-associated variant (RAV) Q80K, known to interfere with the action of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuypers, Lize, Vrancken, Bram, Fabeni, Lavinia, Marascio, Nadia, Cento, Valeria, Di Maio, Velia Chiara, Aragri, Marianna, Pineda-Peña, Andrea Clemencia, Schrooten, Yoeri, Van Laethem, Kristel, Balog, Daniel, Focà, Alfredo, Torti, Carlo, Nevens, Frederik, Perno, Carlo Federico, Vandamme, Anne-Mieke, Ceccherini-Silberstein, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341469/ https://www.ncbi.nlm.nih.gov/pubmed/28270091 http://dx.doi.org/10.1186/s12862-017-0913-3

Ejemplares similares

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
por: Polilli, Ennio, et al.
Publicado: (2016)

Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients
por: Marascio, Nadia, et al.
Publicado: (2016)

Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba
por: Alemán, Yoan, et al.
Publicado: (2015)

A18 Random amplification with next-generation sequencing to cover HIV and HCV full-length genomes
por: Cuypers, L., et al.
Publicado: (2017)

Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development
por: Cuypers, Lize, et al.
Publicado: (2016)

Update on different aspects of HCV variability: focus on NS5B polymerase
por: Marascio, Nadia, et al.
Publicado: (2014)

Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance
por: Cuypers, Lize, et al.
Publicado: (2015)

High frequency of antiviral drug resistance and non-b subtypes in HIV-1 patients failing antiviral therapy in Cuba
por: Kouri, Vivian, et al.
Publicado: (2014)

Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing
por: Vrancken, Bram, et al.
Publicado: (2016)

NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients
por: Bellocchi, Maria Concetta, et al.
Publicado: (2019)

Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
por: Marascio, Nadia, et al.
Publicado: (2019)

Dolutegravir Plus Lamivudine Two-Drug Regimen: Safety, Efficacy and Diagnostic Considerations for Its Use in Real-Life Clinical Practice—A Refined Approach in the COVID-19 Era
por: Cento, Valeria, et al.
Publicado: (2021)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Zika genomics urgently need standardized and curated reference sequences
por: Theys, Kristof, et al.
Publicado: (2017)

Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in Italy
por: Bertoli, Ada, et al.
Publicado: (2018)

The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates
por: Vrancken, Bram, et al.
Publicado: (2014)

The Genotypic False Positive Rate Determined by V3 Population Sequencing Can Predict the Burden of HIV-1 CXCR4-using Species Detected by Pyrosequencing
por: Svicher, Valentina, et al.
Publicado: (2013)

Selected amino acid mutations in HIV-1 B subtype gp41 are Associated with Specific gp120(V3 )signatures in the regulation of Co-Receptor usage
por: Dimonte, Salvatore, et al.
Publicado: (2011)

HIV-1 Gag C-terminal amino acid substitutions emerging under selective pressure of protease inhibitors in patient populations infected with different HIV-1 subtypes
por: Li, Guangdi, et al.
Publicado: (2014)

Sub-Epidemics Explain Localized High Prevalence of Reduced Susceptibility to Rilpivirine in Treatment-Naive HIV-1-Infected Patients: Subtype and Geographic Compartmentalization of Baseline Resistance Mutations
por: Theys, Kristof, et al.
Publicado: (2016)

HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: A systematic review and meta-analysis protocol
por: Nka, Alex Durand, et al.
Publicado: (2021)

Back to the future (of common respiratory viruses)
por: Mattana, Giordana, et al.
Publicado: (2022)

Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework
por: Capina, Rupert, et al.
Publicado: (2020)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol
por: Semengue, Ezechiel Ngoufack Jagni, et al.
Publicado: (2020)

Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice
por: Marascio, Nadia, et al.
Publicado: (2022)

Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?
por: Zicca, Emilia, et al.
Publicado: (2014)

Trends and Predictors of Transmitted Drug Resistance (TDR) and Clusters with TDR in a Local Belgian HIV-1 Epidemic
por: Pineda-Peña, Andrea-Clemencia, et al.
Publicado: (2014)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis
por: Ngoufack Jagni Semengue, Ezechiel, et al.
Publicado: (2022)

Immunity to Human Immunodeficiency Virus (HIV) Infection
por: Torti, Carlo, et al.
Publicado: (2012)

Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level
por: Torti, Carlo, et al.
Publicado: (2021)

Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients
por: Teto, Georges, et al.
Publicado: (2022)

Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort
por: Bartha, István, et al.
Publicado: (2013)

HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors
por: Cento, Valeria, et al.
Publicado: (2012)

Eleven-Year Distribution Pattern of Hepatitis C Virus in Southern Italy
por: Marascio, Nadia, et al.
Publicado: (2012)

Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series
por: Mazzitelli, Maria, et al.
Publicado: (2018)

A Very Low Geno2pheno False Positive Rate Is Associated with Poor Viro-Immunological Response in Drug-Naïve Patients Starting a First-Line HAART
por: Armenia, Daniele, et al.
Publicado: (2014)

Clinical Evaluation of Rega 8: An Updated Genotypic Interpretation System That Significantly Predicts HIV-Therapy Response
por: Vercauteren, Jurgen, et al.
Publicado: (2013)

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C
por: Popping, Stephanie, et al.
Publicado: (2018)

Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?
por: Torti, Carlo, et al.
Publicado: (2011)

Towards a unified classification for human respiratory syncytial virus genotypes
por: Ramaekers, Kaat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ebbkq85vn7fguho40psp8afpj1